Clinical Trials Browser

Phase 2 × Pheochromocytoma × lenvatinib × Clear all

NCT03008369 2024-02-20

Lenvatinib in Treating Patients With Metastatic or Advanced Pheochromocytoma or Paraganglioma That Cannot Be Removed by Surgery

Phase 2 Completed

3 enrolled 9 charts

Paraganglioma, Extra-Adrenal, Pheochromocytoma